peripheral granulocyte count rose to above 500/mm 3 . His bone marrow aspirate showed normocellular marrow with no lymphoblasts on day 33. Immunoglobulin with a high Gianotti-Crosti syndrome (GCS) is characterized by a distinctive self-limiting acral papular or papulovesicular anti-cytomegalovirus (CMV) antibody titer was administered at a dose of 400 mg/kg, three times (total dose eruption associated with an underlying viral illness. It has not been previously reported in patients post-bone 1200 mg/kg), until day 21 as prophylaxis for CMV infection. The anti-CMV IgG titer measured by enzyme-linked marrow transplantation. We report a 6-year-old Japanese boy who underwent allogeneic bone marrow immunosorbent assay (ELISA) was positive, and IgM negative in his serum before BMT. CMV antibody by comptransplantation from an unrelated donor for acute lymphoblastic leukemia (ALL) in second remission. He had lement fixation (CF) in the donor was also positive. Blood transfusion units after BMT were not specifically selected clinical and histopathologic findings characteristic of GCS and evidence of subclinical infection with cytomefrom CMV-negative donors. On day 37, numerous monomorphic 2-to-3 mm diameter galovirus (CMV) detected by CMV antigenemia assay. It is likely that CMV is the causative agent for the GCS erythematous papules with pruritus appeared bilaterally on the dorsum of the hands and feet and spread symmetrically in this case.
CMV immunoglobulin 400 mg/kg on day 41 and ganciclocase. CMV reactivation after BMT was monitored with the human cytomegalovirus (HCMV) antigenemia assay, 5 vir 5 mg/kg twice daily (10 mg/kg/day) from days 41 to 50 for subclinical CMV infection. After day 46, CMV antiwhich uses an indirect alkaline phosphatase staining method for the HCMV antigen in peripheral blood polygenemia was absent. He developed no other symptoms or signs of CMV infection. A biopsy of the skin eruption morphonuclear leukocytes. We monitored HCMV antigenemia after BMT in order to detect subclinical CMV showed hyperkeratosis, acanthosis, focal parakeratosis, exocytosis, and spongiosis of the epidermis with moderate infection and to treat it as soon as possible, because CMV pneumonia is a life-threatening complication known to superficial perivascular mononuclear infiltration of the dermis. There were no conspicuous cellular infiltrates invading occur after BMT. Serological testing for CMV was not reliable in detecting active CMV infection because the the basement membrane, characteristic of GVHD (Figure 2 ). These features are consistent with the diagnosis immune function of the patient was impaired at this time. CMV isolation by culture was not carried out. In this case, of Gianotti-Crosti syndrome. The eruption cleared approximately 20 days later, with desquamation. He has had no HCMV antigenemia was weakly but definitely positive on days 32 and 39. The eruption occurred on day 37 and further dermatologic problems, and no evidence of GVHD.
gradually extended. The simultaneous occurrence of these phenomena may well indicate the close relationship between them. We believe that transient CMV viremia may Discussion have contributed to the acrodermatitis. It is clinically difficult to distinguish the skin eruption of GVHD from GCS, In 1955 Gianotti 1 described a syndrome characterized by an erythematous papular eruption distributed symmetrically because GVHD and CMV infection often occur simultaneously post-BMT. Since CMV infection has been on the face, buttocks and extremities of children. This was originally called papular acrodermatitis of childhood (PAC) reportedly linked to GCS, it should be taken into consideration as a possible diagnosis for a papular eruption occurand was designated Gianotti-Crosti syndrome (GCS) later. An association with hepatitis B infection was first reported ring after BMT. GCS should be considered as a self-limiting complication after BMT, in order to avoid unnecessary by Crosti and Gianotti in 1964. The eruption and acute anicteric hepatitis-associated HBV infection were essential immunosuppressive therapy. The actual pathogenic mechanism of GCS remains feature of GCS. However, identical eruptions associated with numerous other viruses were reported later 2,3 unassounclear. A virus-induced type 4 cutaneous hypersensitivity has been suggested. 6 
GCS can be considered as an indirect ciated with hepatitis B virus (HBV) infection. These cases were called papulovesicular acrolocated syndrome (PAS). consequence of the virus, occurring as a result of an individual immune response to a viral infection. Recently BalaRecently, Caputo et al
4 have made it clear that PAC with HBV infection is clinically indistinguishable from PAS dari et al 7 reported an epidemic of five cases with infantile papular acrodermatitis (GCS) occurring in conjunction with associated with another virus infection. They suggested that differences in clinical manifestations are probably due to Epstein-Barr virus (EBV) infection after a combined diphtheria-tetanus-pertussis-poliomyelitis vaccine given 2 individual characteristics of the patient rather than the causative infectious agent.
to 3 weeks previously. Lacour and Harms 8 reported an 18-month-old girl with GCS who had combined mumpsCytomegalovirus (CMV) has been commonly reported 2, 3 in association with GCS. Antibodies to CMV measured by measles-rubella and Hemophilus vaccine 3 weeks prior to an EBV infection, with seroconversion for EBV occurring enzyme-linked immunosorbent assay (ELISA) and CMV IgG were positive, with negative IgM before BMT in this 2 months later. The authors of these two reports suggested that GCS might be caused by prior immune stimulation followed by a viral infection. However, Cambiaghi et al 9 reported GCS in a 28-year-old patient which developed after influenza virus vaccination and occurred with no evidence of viral infection. They suggested that the vaccination may have triggered GCS. Blauvelt et al 10 reported two patients with GCS associated with human immunodeficiency virus (HIV) infection, in whom CMV was isolated. They emphasized that it would be difficult to document HIV as the etiologic agent for GCS, and suggested that GCS may have been caused by transient CMV viremia on the basis of the immunodeficiency associated with HIV infection. Profound immunodeficiency persists after BMT, as with HIV infection. The CD4 cell count decreases and the CD4 + /CD8 + ratio is low for several months to a year post-BMT. We suggested that the immunodeficiency associated with BMT may well be the basis for GCS in the present case. The development of GCS in conjunction with CMV antigene-
